Muhammad Waheed Rasheed | Artificial Intelligence | Best Researcher Award

Mr. Muhammad Waheed Rasheed | Artificial Intelligence | Best Researcher Award

Research Assistant at COMSATS University Islamabad, Vehari Campus, Pakistan

Muhammad Waheed Rasheed is a dedicated mathematician and researcher known for his contributions to cryptography, fuzzy graph theory, and QSPR analysis. His academic and professional pursuits focus on creating innovative solutions to global challenges, particularly in molecular descriptors, graph theory, and their applications in chemistry and physics. With a passion for research and education, Mr. Rasheed embodies excellence in both theoretical and applied mathematics. His publications in high-impact journals like Frontiers in Chemistry and Frontiers in Physics reflect his ability to bridge disciplines and address real-world problems. As a motivated and dependable team player, he thrives in collaborative environments while excelling independently. His research outputs, which span drug efficacy studies and complex mathematical modeling, contribute significantly to scientific advancements and underscore his role as a rising star in the global mathematical community.

Profile

Scopus

Education 🎓

Mr. Rasheed earned an MS in Mathematics (2021–2023) and a BS (Hons) in Mathematics (2017–2021) from the University of Education Lahore, Pakistan, achieving CGPAs of 3.64/4.00 and 3.61/4.00, respectively. His coursework encompassed advanced topics such as algebraic graph theory, numerical methods, Galois theory, real analysis, and differential geometry. This robust educational foundation equipped him with the analytical and problem-solving skills needed to excel in multidisciplinary research areas, including graph theory and mathematical modeling.

Work Experience đź’Ľ

Muhammad Waheed Rasheed is an accomplished researcher with expertise in cryptography, fuzzy graph theory, and QSPR analysis. His work focuses on molecular descriptors, graph labeling, energy graphs, and metric dimensions, addressing challenges in networking and drug efficacy analysis. With five impactful publications in journals like Frontiers in Chemistry and Frontiers in Physics, he demonstrates excellence in both independent and collaborative research. His ability to tackle complex problems and deliver innovative solutions highlights his readiness for advanced research roles in academia and industry.

Research Interests

Mr. Rasheed’s research interests include cryptography, group theory, fuzzy graph theory, and QSPR analysis. He focuses on molecular descriptors, graph labeling, energy graphs, and metric dimensions, aiming to address critical issues in mathematics and its applications in healthcare and networking.

Research Skills

Muhammad Waheed Rasheed’s research interests lie at the intersection of advanced mathematics and real-world applications. He specializes in cryptography, fuzzy graph theory, and group theory, with a strong emphasis on molecular descriptors, graph labeling, energy graphs, and metric dimensions. His work extends to QSPR (Quantitative Structure-Property Relationship) analysis, where he investigates the properties of chemical compounds, such as alkaloids and medications, to improve therapeutic efficacy and understand their thermodynamic behavior. He is particularly passionate about exploring the role of graph theory in networking and healthcare, focusing on innovative solutions to complex problems. Through his interdisciplinary research, Mr. Rasheed aims to contribute significantly to global challenges, combining theoretical insights with practical applications in chemistry, physics, and beyond.

đź“š Publications

Neighborhood Face Index: A New QSPR Approach for Predicting Physical Properties of Polycyclic Chemical Compounds

  • Authors: A. Raza, M.W. Rasheed, A. Mahboob, M. Ismaeel
  • Journal: International Journal of Quantum Chemistry
  • Year: 2024
  • Volume: 124(24), e27524
  • Citations: 0

Block Cipher Construction Using Minimum Spanning Tree from Graph Theory and Its Application with Image Encryption

  • Authors: M.W. Rasheed, A. Mahboob, M. Bilal, K. Shahzadi
  • Journal: Science Progress
  • Year: 2024
  • Volume: 107(4)
  • Citations: 0

Entropy Measures of Dendrimers Using Degree-Based Indices

  • Authors: A. Ovais, F. Yasmeen, M. Irfan, M.W. Rasheed, S. Kousar
  • Journal: South African Journal of Chemical Engineering
  • Year: 2024
  • Volume: 50, pp. 168–181
  • Citations: 0

Computing Connection-Based Topological Indices of Carbon Nanotubes

  • Authors: E.U. Haq, A. Mahboob, M.W. Rasheed, S. Sattar, M. Waqas
  • Journal: South African Journal of Chemical Engineering
  • Year: 2024
  • Volume: 48, pp. 121–129
  • Citations: 0

QSPR Analysis of Physicochemical Properties and Anti-Hepatitis Prescription Drugs Using a Linear Regression Model

  • Authors: A. Mahboob, M.W. Rasheed, A.M. Dhiaa, I. Hanif, L. Amin
  • Journal: Heliyon
  • Year: 2024
  • Volume: 10(4), e25908
  • Citations: 5

Approximating Properties of Chemical Solvents by Two-Dimensional Molecular Descriptors

  • Authors: A. Mahboob, M.W. Waheed Rasheed, I. Hanif, I. Siddique
  • Journal: International Journal of Quantum Chemistry
  • Year: 2024
  • Volume: 124(1), e27305
  • Citations: 3

Role of Molecular Descriptors in QSPR Analysis of Kidney Cancer Therapeutics

  • Authors: A. Mahboob, M.W. Rasheed, I. Hanif, L. Amin, A. Alameri
  • Journal: International Journal of Quantum Chemistry
  • Year: 2024
  • Volume: 124(1), e27241
  • Citations: 9

Face Irregular Evaluations of Family of Grids

  • Authors: J.H.H. Bayati, A. Ovais, A. Mahboob, M.W. Rasheed
  • Journal: AKCE International Journal of Graphs and Combinatorics
  • Year: 2024 (In Press)
  • Citations: 0

Enhancing Breast Cancer Treatment Selection Through 2TLIVq-ROFS-Based Multi-Attribute Group Decision Making

  • Authors: M.W. Rasheed, A. Mahboob, A.N. Mustafa, Z.A.A. Ali, Z.H. Feza
  • Journal: Frontiers in Artificial Intelligence
  • Year: 2024
  • Volume: 7, 1402719
  • Citations: 0

QSAR Modeling with Novel Degree-Based Indices and Thermodynamics Properties of Eye Infection Therapeutics

  • Authors: M.W. Rasheed, A. Mahboob, I. Hanif
  • Journal: Frontiers in Chemistry
  • Year: 2024
  • Volume: 12, 1383206
  • Citations: 0

Conclusion 

Muhammad Waheed Rasheed is a talented researcher whose academic achievements and innovative research demonstrate a promising career in mathematics and its applications. His dedication, interdisciplinary focus, and impactful publications make him a strong candidate for prestigious accolades and research opportunities.

 

Nicoleta Radu | Microbial biotechnology | Best Scholar Award

Assoc. Prof. Dr. Nicoleta Radu | Microbial biotechnology | Best Scholar Award

Associate Professor at University of Agronomic Sciences and Veterinary Medicine of Bucharest, Romania

Dr. Nicoleta Radu is a distinguished Associate Professor with extensive expertise in life sciences and engineering sciences. Her academic and professional journey spans over two decades, during which she has significantly contributed to biotechnology, bioethics, and engineering. She currently serves as an Associate Professor at the Doctoral School of Biotechnology, University of Agronomic Sciences and Veterinary Medicine, Bucharest. She has played pivotal roles in academic and research organizations, including as Head of Education and Bioethics Commission in the Romanian Society of Bioengineering and Biotechnology. Dr. Radu’s research portfolio is interdisciplinary, focusing on medical biotechnology, therapeutic nanomaterials, biofertilizers, and biostimulants for sustainable agriculture. Her efforts have led to innovative solutions that address pressing global challenges in healthcare and sustainability. Beyond her research, she is an active mentor and educator, guiding doctoral students and young researchers. Her leadership and scholarly contributions are reflected in her collaborations with international journals and as an evaluator for prestigious European programs. Dr. Radu’s career is marked by a commitment to fostering ethical research practices and driving innovation in biotechnology and engineering sciences. Her work continues to influence academic, scientific, and industrial landscapes globally.

Profile

Google Scholar

Orcid

Education 🎓

Dr. Nicoleta Radu’s academic foundation reflects a deep and diverse engagement with life sciences and engineering. She earned her Ph.D. in Engineering Science in 2005 from the University POLITEHNICA of Bucharest, a testament to her commitment to advanced research. Her passion for interdisciplinary learning is evident from her two Master’s degrees: one in Biotechnology in 2010 and another in Inorganic Chemistry in 1995, both from the University POLITEHNICA. These degrees equipped her with a unique combination of skills, blending chemical expertise with biotechnological applications. She also holds a Bachelor’s degree in Engineering Science, completed in 1994, which laid the groundwork for her prolific career. Over the years, her continuous learning and integration of multiple scientific disciplines have been instrumental in shaping her research approach. Dr. Radu’s educational journey demonstrates her dedication to mastering the complexities of science and technology, which has enabled her to tackle challenging research problems. Her qualifications highlight her intellectual rigor and her ability to navigate the intersections of chemistry, biology, and engineering, making her a versatile academician and researcher.

Work Experience đź’Ľ

Dr. Nicoleta Radu’s professional career is marked by a blend of academic leadership, research innovation, and organizational contributions. With over 25 years of experience, she has consistently demonstrated excellence in teaching, research, and management. She began her career as a scientist at INCDCP Bucharest, where she contributed to significant advancements in life sciences and engineering sciences. Since 2020, she has been serving as an Associate Professor at the Doctoral School of Biotechnology, University of Agronomic Sciences and Veterinary Medicine, Bucharest. In this role, she mentors doctoral students, conducts advanced research, and contributes to the development of innovative biotechnological solutions. Dr. Radu also served as the Head of Education and Bioethics Commission for the Romanian Society of Bioengineering and Biotechnology, where she emphasized ethical practices in research and education. Her professional experience includes collaborations with international organizations, participation in European research programs, and involvement in cross-disciplinary projects. Dr. Radu’s career trajectory reflects her commitment to pushing the boundaries of knowledge while maintaining the highest standards of academic and scientific integrity. Her roles in education and bioethics further highlight her dedication to fostering an environment of innovation and responsibility.

Awards and Honors

Dr. Nicoleta Radu’s contributions to science and academia have earned her several accolades and prestigious roles. She has been a reviewer for leading international journals such as the International Journal of Molecular Sciences and Genes, reflecting her expertise in her field. As an evaluator for European programs like COST, EUREKA, and INNOWIDE, Dr. Radu has been instrumental in shaping research initiatives at the continental level. These responsibilities highlight her reputation as a trusted and knowledgeable scientific evaluator. Her work has also been recognized through invitations to participate in global conferences and collaborations with renowned research institutions. Dr. Radu’s honors reflect her impact on the scientific community, her leadership in fostering ethical research practices, and her commitment to advancing biotechnological innovations. These accolades not only underscore her professional excellence but also inspire her continued efforts to contribute meaningfully to science and society.

Research Interests

Dr. Nicoleta Radu’s research interests lie at the intersection of biotechnology, engineering sciences, and sustainability. Her work focuses on medical biotechnology, where she has contributed to developing therapeutic nanomaterials that hold promise for advancing healthcare. Another significant area of her research is sustainable agriculture, where she investigates the use of biofertilizers and biostimulants to improve crop productivity while minimizing environmental impact. Dr. Radu’s interdisciplinary approach integrates cutting-edge technologies with ethical considerations, ensuring that her work addresses global challenges responsibly. She is particularly interested in bioethics, striving to promote responsible practices in the scientific community. Her research also explores the potential of novel biotechnological methods to address pressing issues in food security, environmental sustainability, and medical innovation. Dr. Radu’s ability to bridge multiple fields positions her as a leader in addressing complex problems through a holistic scientific lens. Her contributions to these areas not only advance academic knowledge but also provide practical solutions with far-reaching implications for society and industry.

Research Skills

Dr. Nicoleta Radu possesses a robust set of research skills that underpin her success in interdisciplinary scientific investigations. She is adept at using modern modeling and statistical tools, including Fuzzy Tech, Neural Networks, and Table Curve 3D, which enable her to analyze complex data and develop predictive models. Her proficiency in both Mac OS and Windows environments ensures seamless adaptability to various software platforms. Dr. Radu has honed her skills in designing and implementing biotechnological methods, with a focus on therapeutic systems and sustainable agricultural solutions. She excels in laboratory techniques related to nanomaterials, biofertilizers, and biostimulants, demonstrating her technical expertise. Additionally, her ability to integrate bioethical principles into her research showcases her commitment to responsible science. Her collaborative skills and ability to lead multidisciplinary teams have been instrumental in advancing her research objectives. Dr. Radu’s technical acumen, combined with her innovative mindset, enables her to contribute significantly to complex scientific challenges while maintaining a focus on ethical and sustainable practices.

đź“š Publications

Cladosporium sp. Isolate as Fungal Plant Growth Promoting Agent

  • Journal: Agronomy
  • Year: 2021
  • Citations: 63

Fungal-Based Biopolymer Composites for Construction Materials

  • Journal: Materials
  • Year: 2021
  • Citations: 41

Antimicrobial Effect of Monascus purpureus Red Rice Against Some Bacterial and Fungal Strains

  • Journal: New Biotechnology
  • Year: 2009
  • Citations: 29

The Effect of Resveratrol or Curcumin on Head and Neck Cancer Cells Sensitivity to the Cytotoxic Effects of Cisplatin

  • Journal: Nutrients
  • Year: 2020
  • Citations: 23

Cisplatin Effect on Head and Neck Squamous Cell Carcinoma Cells is Modulated by ERK1/2 Protein Kinases

  • Journal: Experimental and Therapeutic Medicine
  • Year: 2019
  • Citations: 23

Resveratrol Modulation of Apoptosis and Cell Cycle Response to Cisplatin in Head and Neck Cancer Cell Lines

  • Journal: International Journal of Molecular Sciences
  • Year: 2021
  • Citations: 22

Ganoderma lucidum-Mediated Green Synthesis of Silver Nanoparticles with Antimicrobial Activity

  • Journal: Materials
  • Year: 2023
  • Citations: 21

Studies Regarding the Pharmaceutical Potential of Derivative Products from Plantain

  • Contributors: MGO Zaharie, N Radu, L Pirvu, M Bostan, M Voicescu, M Begea, …

Conclusion 

Assoc. Prof. Dr. Nicoleta Radu is a strong candidate for the Research for Best Scholar Award. Her vast experience, leadership roles, interdisciplinary expertise, and significant academic contributions make her highly deserving. Enhancing the profile with quantitative research metrics and recent impactful projects could further solidify her application. Overall, she exemplifies a dedicated scholar with a substantial impact on the fields of biotechnology and engineering sciences.

 

Sayed Abdi | Cardiovascular | Best Researcher Award

Dr. Sayed Abdi | Cardiovascular | Best Researcher Award

Research assistant at University of Arkansas for Medical Science, United States

Dr. Sayed Abdi is a distinguished toxicologist and researcher with a strong academic foundation and extensive international experience. He completed his PhD in Toxicology from Jamia Hamdard University, focusing on chemotherapy-induced urotoxicity and its molecular mechanisms. With over a decade of research and teaching experience, Dr. Abdi has contributed significantly to toxicology, pharmacology, and molecular biology. His work emphasizes developing innovative therapeutic approaches to minimize drug toxicity and improve patient outcomes. Dr. Abdi has held roles in prestigious institutions across India, Saudi Arabia, and the United States, showcasing his adaptability and commitment to advancing scientific knowledge. He has published extensively in peer-reviewed journals and actively participates in collaborative research projects.

Profile

Google Scholar

 

Education 🎓

Dr. Sayed Abdi’s academic journey is rooted in excellence. He earned his PhD in Toxicology in December 2017 from Jamia Hamdard University, New Delhi, India. His doctoral research focused on the development of murine models to understand chemotherapy-induced hemorrhagic cystitis. He holds a Master’s degree in Pharmacy Practice from JSS College of Pharmacy, Mysore, completed in March 2011. His undergraduate degree in Pharmacy was also obtained from Jamia Hamdard University in December 2008. This robust academic background has equipped him with the theoretical and practical expertise required for cutting-edge research in toxicology, pharmacology, and molecular biology.

Work Experience đź’Ľ

Dr. Abdi’s professional experience spans diverse roles in academia and research. As a Research Assistant II at the University of Arkansas, he performs laboratory experiments and clinical trials of nutraceuticals. Prior roles include Research Assistant at the University of Tennessee, where he conducted molecular biology experiments and mouse behavioral studies, and a Postdoctoral Fellow at the Medical College of Wisconsin, focusing on NGS and RNA sequencing. From 2018 to 2022, Dr. Abdi served as an Assistant Professor at Al-Baha University, Saudi Arabia, mentoring students and conducting computational modeling, molecular dynamics simulations, and disease model development. His global career reflects a commitment to advancing toxicology and molecular biology research through collaborative and innovative projects.

Awards and Honors

Dr. Abdi’s dedication to research and teaching has earned him recognition in academia. While specific awards are not detailed, his global academic and research roles at prestigious institutions reflect his reputation as a highly skilled researcher. His contributions to understanding chemotherapy toxicity and therapeutic interventions are widely acknowledged. Additionally, his ability to secure research positions in top institutions like the University of Arkansas, University of Tennessee, and Al-Baha University demonstrates his academic excellence and professional commitment. Dr. Abdi’s impactful publications further underscore his expertise and dedication to advancing toxicology and pharmacology.

Research Interests

Dr. Abdi’s research interests revolve around molecular toxicology, pharmacology, and the development of therapeutics to mitigate chemotherapy-induced side effects. His work on cyclophosphamide-induced urotoxicity highlights his dedication to understanding drug toxicity at the molecular level. He is also passionate about natural antioxidants as potential therapeutic agents, bridging the gap between pharmacology and nutraceuticals. His interests extend to computational biology, exploring protein modeling, molecular docking, and dynamics simulations to predict therapeutic targets. With a strong focus on clinical applications, Dr. Abdi aims to develop innovative solutions that enhance drug safety and efficacy, contributing to improved patient outcomes.

Research Skills

Dr. Abdi is proficient in various advanced research techniques. His molecular biology expertise includes PCR, qRT-PCR, Western blotting, and RNA sequencing. In toxicology, he specializes in developing murine disease models, drug safety studies, and chemokine/cytokine analysis. He is skilled in flow cytometry for cell analysis and sorting, as well as tissue culture techniques for cytotoxicity assays. His computational biology skills encompass molecular docking, dynamics simulations, and protein modeling using software like GROMACS and AutoDock. Dr. Abdi’s comprehensive skill set enables him to approach research problems from multiple angles, integrating molecular biology, toxicology, and computational methods for impactful outcomes.

đź“š Publications

Mitochondrial Dysfunction Induced by Bisphenol A is a Factor of its Hepatotoxicity in Rats

  • Journal: Environmental Toxicology
  • Year: 2016
  • Citations: 115

Study of Drug Utilization Pattern of Antihyperglycemic Agents in a South Indian Tertiary Care Teaching Hospital

  • Journal: Indian Journal of Pharmacology
  • Year: 2012
  • Citations: 61

Multi-Epitope-Based Vaccine Candidate for Monkeypox: An In Silico Approach

  • Journal: Vaccines
  • Year: 2022
  • Citations: 32

The Protective Effect of α-Lipoic Acid Against Bisphenol A-Induced Neurobehavioral Toxicity

  • Journal: Neurochemistry International
  • Year: 2018
  • Citations: 29

Anti-Inflammatory Role of Tempol (4-Hydroxy-2, 2, 6, 6-Tetramethylpiperidin-1-Oxyl) in Nephroprotection

  • Journal: Human & Experimental Toxicology
  • Year: 2019
  • Citations: 14

Cyclophosphamide-Induced Down-Regulation of Uroplakin II in the Mouse Urinary Bladder Epithelium is Prevented by S-Allyl Cysteine

  • Journal: Basic & Clinical Pharmacology & Toxicology
  • Year: 2016
  • Citations: 13

Sunscreen Ingredient Octocrylene’s Potency to Disrupt Vitamin D Synthesis

  • Journal: International Journal of Molecular Sciences
  • Year: 2022
  • Citations: 12

Conclusion 

Dr. Sayed Abdi is a strong contender for the “Research for Best Researcher Award” due to his outstanding educational background, diverse research experience, technical expertise, and impactful contributions to toxicology and pharmaceutical sciences. With further emphasis on high-impact publications, grant acquisition, and leadership roles, he can elevate his already impressive profile to new heights.

 

Ling Mei | Cognitive Science | Best Researcher Award

Dr. Ling Mei | Cognitive Science | Best Researcher Award

Doctorate at Wuhan University of Science and Technology, China

Dr. Ling Mei is an accomplished researcher in artificial intelligence and cognitive science, with a robust academic and professional background. He holds a Ph.D. in Engineering from Sun Yat-sen University, one of China’s top universities, and completed a prestigious visiting scholar program at the University of British Columbia (UBC). Currently serving as a tenured faculty and master’s supervisor, Dr. Mei has published 16 papers, including 7 in SCI-indexed journals, contributed to nine books, and has three national invention patents granted. Recognized as a Provincial Research Talent of China in 2024, he work integrates advanced computational models with societal needs, such as urban planning and public safety. Dr. Mei has collaborated internationally with top-tier institutions like UBC and Carnegie Mellon University, cementing he reputation as a leader in he field.

Profile

Google Scholar

Orcid

Education 🎓

Dr. Mei earned he Ph.D. in Engineering from Sun Yat-sen University in 2021, a prestigious institution ranked among China’s top 10 universities. He academic journey also includes a year-long visiting scholar program at the Department of Computer Science, UBC, as part of the National Outstanding Young Researchers Program. This international exposure provided he with cutting-edge knowledge and interdisciplinary skills, enabling he to excel in artificial intelligence and cognitive science.

Work Experience đź’Ľ

Currently, Dr. Mei is a tenured faculty member and master’s supervisor at a leading Chinese university. He experience includes overseeing multiple research projects, consulting on seven industry-sponsored projects, and serving as a reviewer for the IEEE TRANSACTIONS ON CIRCUITS AND SYSTEMS FOR VIDEO TECHNOLOGY. He has also been instrumental in fostering international collaborations with institutions like UBC and CMU, contributing to impactful research publications and patents.

Awards and Honors

In 2024, Dr. Mei was recognized as a Provincial Research Talent of China, highlighting he exceptional contributions to science and technology. He has also earned accolades through he impactful patents and high-quality publications.

Research Interests

Dr. Mei’s research focuses on artificial intelligence, pedestrian trajectory prediction, and public safety strategies. He innovations include the LSN-GTDA framework, which integrates behavioral and stochastic factors for better uncertainty management. He interdisciplinary approach bridges cognitive science, computational models, and societal applications, ensuring he work’s relevance and impact.

Research Skills

Dr. Mei possesses advanced skills in AI modeling, thermal diffusion processes, and signal and system theory. He expertise includes patent development, SCI journal publications, and interdisciplinary collaborations. He is adept at integrating computational techniques with practical applications, as seen in he trajectory prediction research.

đź“š Publications

Crowd Density Estimation via Global Crowd Collectiveness Metric

  • Journal: Drones
  • Date: 2024-10-28
  • DOI: 10.3390/drones8110616
  • Contributors: Ling Mei, Mingyu Yu, Lvxiang Jia, Mingyu Fu

More Quickly-RRT: Improved Quick Rapidly-Exploring Random Tree Star Algorithm Based on Optimized Sampling Point with Better Initial Solution and Convergence Rate*

  • Journal: Engineering Applications of Artificial Intelligence
  • Date: 2024-07
  • DOI: 10.1016/j.engappai.2024.108246
  • Contributors: Xining Cui, Caiqi Wang, Yi Xiong, Ling Mei, Shiqian Wu

Learning Domain-Adaptive Landmark Detection-Based Self-Supervised Video Synchronization for Remote Sensing Panorama

  • Journal: Remote Sensing
  • Date: 2023-02-09
  • DOI: 10.3390/rs15040953
  • Contributors: Ling Mei, Yizhuo He, Farnoosh Fishani, Yaowen Yu, Lijun Zhang, Helge Rhodin

Illumination-Invariance Optical Flow Estimation Using Weighted Regularization Transform

  • Journal: IEEE Transactions on Circuits and Systems for Video Technology
  • Date: 2020-02
  • DOI: 10.1109/TCSVT.2019.2890861
  • Contributors: Ling Mei, Jianhuang Lai, Xiaohua Xie, Junyong Zhu, Jun Chen

Feature Visualization Based Stacked Convolutional Neural Network for Human Body Detection in a Depth Image

  • Type: Book Chapter
  • Year: 2018
  • DOI: 10.1007/978-3-030-03335-4_8
  • Contributors: Xiao Liu, Ling Mei, Dakun Yang, Jianhuang Lai, Xiaohua Xie

Conclusion 

Dr. Ling Mei is a strong contender for the Best Researcher Award due to he robust academic background, impactful research, and significant contributions to AI and cognitive science. To further enhance he candidacy, increasing citation influence and emphasizing community impact would solidify he position as an exemplary researcher deserving of recognition. 🌟

 

Rohit Pal | Pharmaceutical Chemistry | Young Scientist Award

Mr. Rohit Pal | Pharmaceutical Chemistry | Young Scientist Award

PhD Scholar at Acharya and BM Reddy College of Pharmacy, Bengaluru, India

Mr. Rohit Pal is a dedicated and emerging researcher in the field of pharmaceutical sciences, particularly focusing on drug discovery and development. Currently pursuing his Ph.D. at Acharya & BM Reddy College of Pharmacy in Bengaluru, he is engaged in innovative research on Pyrimidine derivatives as fourth-generation EGFR inhibitors to combat Non-Small Cell Lung Cancer (NSCLC). With a strong academic background, including an M.Pharmacy in Pharmaceutical Chemistry, Mr. Pal combines his expertise in chemical synthesis with cutting-edge computational techniques like molecular docking and structure-activity relationship (SAR) analysis. His work spans multiple research areas, including anticonvulsant activity, anti-inflammatory research, and the pharmacognostic standardization of endangered species like Passiflora vitifolia. Throughout his career, Mr. Pal has demonstrated a capacity for both in-silico drug design and experimental testing, balancing theoretical approaches with hands-on experimentation. His impressive publication record in respected journals further showcases his capability to contribute to the scientific community. As a promising young researcher, Mr. Pal’s ongoing work not only advances pharmaceutical sciences but also holds potential for meaningful clinical applications in cancer therapy and drug design.

Profile

Orcid

 

Education 🎓

Mr. Rohit Pal’s educational background demonstrates a consistent pursuit of excellence in the field of pharmaceutical sciences. He is currently enrolled in a Ph.D. program at Acharya & BM Reddy College of Pharmacy in Bengaluru, Karnataka, where his research is focused on the development of Pyrimidine derivatives as EGFR inhibitors to target Non-Small Cell Lung Cancer (NSCLC). Prior to his doctoral studies, Mr. Pal completed his M.Pharmacy in Pharmaceutical Chemistry from ISF College of Pharmacy in Moga, Punjab, achieving a notable CGPA of 9.07. His academic journey began with a B. Pharmacy from Dev Bhoomi Institute of Pharmacy and Research, Dehradun, where he gained a robust foundation in pharmaceutical sciences. Additionally, Mr. Pal holds a D. Pharmacy from SGGS College of Pharmacy, Chandigarh, further demonstrating his dedication to the field from the onset of his academic career. His varied educational experiences have shaped his interdisciplinary approach to pharmaceutical research, combining knowledge from chemistry, biology, and computational sciences. This solid academic foundation has propelled Mr. Pal to explore complex drug development challenges, particularly in cancer therapy, with a keen interest in molecular-level drug interactions.

Work Experience đź’Ľ

Mr. Rohit Pal’s professional experience reflects a promising trajectory in pharmaceutical research and drug discovery. As a Ph.D. scholar at Acharya & BM Reddy College of Pharmacy, he is deeply involved in researching Pyrimidine derivatives for EGFR inhibition in Non-Small Cell Lung Cancer (NSCLC). His research explores the design, synthesis, and evaluation of novel drug candidates, combining in-vitro testing with computational drug design. Through the use of molecular docking and structure-activity relationship (SAR) analysis, Mr. Pal aims to identify compounds with high therapeutic potential. Beyond his Ph.D. work, Mr. Pal has worked on various other research projects, including 1,2,4-triazine derivatives for anticonvulsant activity and the anti-inflammatory properties of Passiflora vitifolia, an endangered plant species. His work spans both synthetic chemistry and biological testing, allowing him to gain expertise in pharmacological assays and computational modeling. Mr. Pal’s professional experience also includes using sophisticated instruments such as HPLC, UV spectrophotometers, and Microwave Synthesizers, which complement his experimental work and ensure the reliability of his results. These experiences have positioned him well for future leadership roles in pharmaceutical research and drug developmen

Awards and Honors

Although still in the early stages of his academic career, Mr. Rohit Pal has already garnered significant recognition for his research efforts. His academic excellence is reflected in his M.Pharmacy CGPA of 9.07, placing him among the top students in his cohort. Mr. Pal’s research has been published in reputable journals such as the Journal of Biomolecular Structure and Dynamics and Chemical Physics Impact, demonstrating the impact and quality of his work. These publications are indicative of his ability to produce research that contributes to the scientific community. Despite being early in his career, his involvement in cutting-edge research on Pyrimidine derivatives and EGFR inhibitors has already gained attention within the academic and pharmaceutical fields. His dedication to molecular docking, drug design, and pharmacognostic studies positions him for further recognition. As Mr. Pal continues to contribute to innovative drug development solutions, he is likely to receive more prestigious awards and honors, reflecting the growing importance of his work in cancer research and pharmaceutical chemistry.

Research Interests

Mr. Rohit Pal’s research interests are centered around the intersection of pharmaceutical chemistry and drug discovery. His primary focus is on developing Pyrimidine derivatives as fourth-generation EGFR inhibitors aimed at Non-Small Cell Lung Cancer (NSCLC), a serious health concern with limited therapeutic options. By targeting the epidermal growth factor receptor (EGFR), his work could offer more effective treatment alternatives for cancer patients. In addition to cancer research, Mr. Pal has explored 1,2,4-triazine derivatives for evaluating anticonvulsant activity, contributing to neurological disorder treatments. He is also interested in anti-inflammatory research, with a particular focus on Passiflora vitifolia, an endangered plant species, aiming to standardize its pharmacognostic properties. His multidisciplinary approach extends to the application of computational drug design, where he utilizes molecular docking and molecular dynamics simulations to predict drug-receptor interactions. Mr. Pal is committed to advancing drug development by combining experimental chemistry with in-silico methodologies, offering innovative solutions for complex healthcare challenges. His work on drug repurposing, targeted therapies, and sustainable drug sourcing reflects his holistic approach to addressing both scientific and global health concerns.

Research Skills

Mr. Rohit Pal possesses a wide range of research skills essential for successful pharmaceutical research. His proficiency in chemical synthesis includes techniques such as recrystallization, sublimation, and flash chromatography, which he applies to purify and isolate new compounds for testing. In addition to these laboratory techniques, Mr. Pal is highly skilled in analytical methods, including HPLC and UV spectrophotometry, to assess the purity and chemical composition of compounds. He is also adept at utilizing computational tools for drug design, particularly AutoDock, Biovia Drug Discovery Studio, and Pymol, to perform molecular docking and molecular dynamics simulations. These tools allow him to predict the interactions between drug candidates and their targets, enhancing the efficiency of drug development. Furthermore, Mr. Pal has experience in in-vitro biological testing, including assays for anticonvulsant, anti-inflammatory, and antioxidant activities, ensuring the biological relevance of his synthesized compounds. His ability to combine experimental techniques with computational modeling equips him to approach drug discovery from both theoretical and practical angles, ensuring well-rounded and impactful research outcomes.

đź“š Publications

  • Design, synthesis, and biological evaluation of novel 4-(4-ethoxyphenyl)-6-(substituted-phenyl)pyrimidin-2-amine/thiol/hydroxy derivatives as EGFRWT and EGFRT790M inhibitors targeting NSCLC: In-vitro and in-silico exploration
    • Journal: Journal of Molecular Structure
    • DOI: 10.1016/j.molstruc.2024.141227
    • Date: April 2025
    • Contributors: Rohit Pal; Gurubasavaraja Swamy Purawarga Matada; Ghanshyam Teli; Viney Chawla; Pooja A. Chawla
  • Next-generation cancer therapeutics: PROTACs and the role of heterocyclic warheads in targeting resistance
    • Journal: European Journal of Medicinal Chemistry
    • DOI: 10.1016/j.ejmech.2024.117034
    • Date: January 2025
    • Contributors: Ebna Azizal Omar; Rajesh R.; Pronoy Kanti Das; Rohit Pal; Gurubasavaraja Swamy Purawarga Matada; Lalmohan Maji
  • Benzothiazole a privileged scaffold for cutting-edge anticancer agents: Exploring drug design, structure-activity relationship, and docking studies
    • Journal: European Journal of Medicinal Chemistry
    • DOI: 10.1016/j.ejmech.2024.116831
    • Date: December 2024
    • Contributors: Aayishamma I; Gurubasavaraja Swamy Purawarga Matada; Rohit Pal; Abhishek Ghara; Nimmagadda Venkata Satya Sai Aishwarya; Kumaraswamy B; Ketan R. Hosamani; Manjushree B V; Haripriya E
  • An outlook of docking analysis and structure-activity relationship of pyrimidine-based analogues as EGFR inhibitors against non-small cell lung cancer (NSCLC)
    • Journal: Journal of Biomolecular Structure and Dynamics
    • DOI: 10.1080/07391102.2023.2252082
    • Date: December 11, 2024
    • Contributors: Rohit Pal; Ghanshyam Teli; Sindhuja Sengupta; Lalmohan Maji; Gurubasavaraja Swamy Purawarga Matada
  • Exploring the anticancer potential of triazine derivatives: An outlook of designing strategies, docking studies, and structure-activity relationships (SAR)
    • Journal: ChemistrySelect
    • DOI: 10.1002/slct.202402766
    • Date: November 2024
    • Contributors: B. V. Manjushree; Gurubasavaraja Swamy Purawarga Matada; Rohit Pal; Md. Ashadul Sk; M. P. Viji; Nimmagadda Venkata Satya Sai Aishwarya; Pronoy Kanti Das; I. Aayishamma; S. Mounika
  • Pyrazole, pyrazoline, and fused pyrazole derivatives: New horizons in EGFR-targeted anticancer agents
    • Journal: Chemistry & Biodiversity
    • DOI: 10.1002/cbdv.202400880
    • Date: November 2024
    • Contributors: Ketan R Hosamani; Hemalatha K; Rohit Pal; Gurubasavaraja Swamy Purawarga Matada; Kumaraswamy B; Aayishamma I; Nimmagadda Venkata Satya Sai Aishwarya

Conclusion 

Mr. Rohit Pal is an exceptionally talented and promising researcher in the field of pharmaceutical sciences. His research, focused on Pyrimidine derivatives as EGFR inhibitors for Non-Small Cell Lung Cancer (NSCLC), is not only innovative but holds significant promise for advancing cancer treatment. His combination of chemical synthesis, computational drug design, and biological testing reflects his multidisciplinary approach to pharmaceutical research. Mr. Pal’s commitment to anti-inflammatory, anticonvulsant, and pharmacognostic standardization further demonstrates his versatility as a researcher. While still in the early stages of his career, his publication record and expertise in molecular docking and drug design suggest that he is well on his way to becoming a leader in pharmaceutical research. His ongoing work could contribute to groundbreaking advancements in cancer therapy, neurological disorder treatments, and sustainable drug sourcing. With his strong educational background, solid professional experience, and growing body of work, Mr. Rohit Pal is undoubtedly a candidate with the potential to make meaningful contributions to drug development and global health. His future in research looks bright, and he is well-positioned for recognition in upcoming awards such as the Young Scientist Award.

 

Rakesh Meena | Applied Mathematics | Best Researcher Award

Mr. Rakesh Meena | Applied Mathematics | Best Researcher Award

Research Scholar at Sardar Vallabhbhai National Institute of Technology, India

Mr. Rakesh Meena is a promising researcher and Ph.D. candidate at the Department of Mathematics, Sardar Vallabhbhai National Institute of Technology (SVNIT), Surat, India. His academic journey is characterized by a focus on advanced mathematical modeling, fractional calculus, and differential equations. With a blend of theoretical and computational expertise, Mr. Meena is dedicated to contributing to innovative solutions in applied mathematics, particularly in areas like epidemic modeling and dynamic systems. He is driven by the desire to combine research with teaching to foster academic growth and knowledge sharing. Throughout his career, he has earned recognition through prestigious scholarships and fellowships, such as the Junior Research Fellowship (JRF) and Senior Research Fellowship (SRF) from CSIR-UGC. His research contributions, including numerous journal publications and conference presentations, reflect his deep commitment to advancing mathematical sciences. Mr. Meena’s aspirations align with the goal of bringing meaningful change to both the academic community and society through his research and teaching.

Profile

Scopus

Google Scholar

Orcid

 

Education 🎓

Mr. Rakesh Meena’s educational background forms a solid foundation for his research career. He began his academic journey at Sardar Vallabhbhai National Institute of Technology (SVNIT), Surat, where he completed his Five-Year Integrated M.Sc. in Mathematics with first division in 2020. Following this, he embarked on his Ph.D. in Mathematics, with a focus on linear and nonlinear fractional differential equations. Under the guidance of Dr. Sushil Kumar, he has made notable progress in mathematical modeling, particularly through the semi-analytical approach. His cumulative performance during his Ph.D. coursework reflects dedication, maintaining a CGPA of 7.25. Throughout his education, Mr. Meena has demonstrated a continuous pursuit of knowledge, aiming to contribute to the vast field of mathematical sciences. His educational path has not only provided him with strong analytical skills but also a deep understanding of both theoretical and computational methods. This educational experience, combined with his passion for research, serves as a solid launchpad for his future contributions to the scientific community.

Work Experience đź’Ľ

Mr. Rakesh Meena’s professional experience includes extensive academic research at the Department of Mathematics, SVNIT, Surat. Currently pursuing his Ph.D., Mr. Meena has contributed to a range of mathematical research, particularly in fractional calculus, epidemic modeling, and nonlinear differential equations. His expertise in using semi-analytical methods, such as the Residual Power Series (RPS) method and Homotopy Analysis Method, allows him to solve complex mathematical equations, which are pivotal in the fields of mathematical modeling and computational mathematics. As a junior and senior research fellow (JRF/SRF), he has been involved in multiple research projects that align with his goal of applying mathematical theory to real-world problems. Additionally, Mr. Meena has shared his research findings through several journal articles and conference papers, expanding his influence in academic circles. Beyond research, his role in mentoring and teaching aligns with his long-term goal of working in an institution where teaching and research go hand-in-hand. His participation in both national and international conferences further strengthens his professional experience, offering him a platform to engage with global research communities.

Awards and Honors

Mr. Rakesh Meena has been the recipient of several prestigious awards and fellowships, recognizing his academic excellence and research potential. In 2020, he was awarded the Junior Research Fellowship (JRF) by CSIR-UGC, which was followed by the Senior Research Fellowship (SRF) in 2022. These fellowships are granted to outstanding researchers in the field of mathematical sciences and are a testament to his proficiency and dedication to research. Additionally, Mr. Meena qualified for GATE (Graduate Aptitude Test in Engineering) in both 2022 and 2023, further cementing his academic credentials. His work, particularly in mathematical modeling and fractional calculus, has earned him recognition in the academic community. His achievements also include being a recipient of certification from CSIR-HRDG, highlighting his commitment to continuous learning and development. These awards and honors reflect Mr. Meena’s dedication to pushing the boundaries of mathematical research, and they serve as a foundation for his continued contributions to the scientific community.

Research Interests

Mr. Rakesh Meena’s primary research interests lie in mathematical modeling, fractional differential equations, and dynamic systems. His doctoral research specifically focuses on linear and nonlinear fractional differential equations, employing semi-analytical methods for their solutions. He aims to explore these equations’ applications in real-world phenomena, such as epidemic modeling, fluid dynamics, and wave propagation. His work in fractional calculus offers new insights into the mathematical descriptions of complex systems, which are often difficult to model using traditional integer-order differential equations. Through his research, Mr. Meena is particularly interested in understanding the behavior of systems with memory and hereditary properties, common in biological and physical systems. In addition to his work on differential equations, he is exploring the application of the Residual Power Series (RPS) method and other numerical techniques, such as the Euler and Runge-Kutta methods, to obtain approximate solutions to these complex models. His interdisciplinary approach to mathematical modeling promises to contribute to both the advancement of mathematical theory and its practical applications in fields like epidemiology, physics, and engineering.

Research Skills

Mr. Rakesh Meena’s research skills are diverse, encompassing both theoretical and computational techniques. His proficiency in mathematical modeling, especially in the context of fractional differential equations, stands out as a major strength. He is well-versed in various semi-analytical methods, notably the Residual Power Series (RPS) and Homotopy Analysis Method, to solve complex differential equations. These techniques are especially useful in capturing the dynamics of systems governed by fractional order equations, which are prevalent in many natural and social systems. Mr. Meena also possesses strong numerical skills, applying methods like the Euler method, Runge-Kutta method, and finite difference methods for computational analysis. He is skilled in using computational tools, including MATLAB, Maple, Mathematica, and LaTeX, to model, analyze, and visualize mathematical problems. His ability to integrate both analytical and numerical methods enables him to approach research challenges from a comprehensive perspective. Moreover, his academic rigor and attention to detail contribute to his systematic approach to research, making his work both reliable and impactful.

đź“š Publications

Conclusion 

Mr. Rakesh Meena is a strong contender for the Best Researcher Award due to his excellent academic record, innovative research in fractional differential equations, and contribution to mathematical modeling. His expertise in semi-analytical and numerical methods provides significant value to his field. With a broader impact focus and increased public engagement, he has the potential to make transformative contributions to both academia and society. This will further cement his position as a leader in his field. 🌟

 

Xiaoling Tan | Plant Protection | Best Scholar Award

Prof. Xiaoling Tan | Plant Protection | Best Scholar Award

Associate Professor at Institute of Plant Protection, Chinese Academy of Agricultural Sciences, China

Dr. Xiaoling Tan is an accomplished associate professor at the Institute of Plant Protection, Chinese Academy of Agricultural Sciences. With a Ph.D. from Northwest A&F University and postdoctoral research at the Institute of Zoology, Chinese Academy of Sciences, her academic journey reflects excellence. She is a respected member of prestigious committees, including the China Biological Control and Insect Ecology Committees of the Chinese Entomological Society. Her work in insect molecular ecology and sustainable pest control has gained international recognition, including collaborative research at the Rothamsted Research Institute, UK. Dr. Tan has spearheaded 19 high-impact projects, developed green wheat pest control technologies, published over 50 high-ranking articles, and received several prestigious awards. She is also an active editor and reviewer for leading scientific journals.

Profile

Orcid

Education 🎓

Dr. Tan earned her Ph.D. in 2014 from Northwest A&F University. Following this, she pursued postdoctoral research from 2014 to 2016 at the Institute of Zoology, Chinese Academy of Sciences, focusing on entomology and pest management. Her commitment to advancing her expertise led her to international collaboration at the Rothamsted Research Institute, UK, from 2018 to 2019.

Work Experience đź’Ľ

Dr. Tan has been an associate professor at the Institute of Plant Protection, Chinese Academy of Agricultural Sciences, since 2016. She has played a pivotal role in national and international research projects, collaborated globally, and trained over 400 agricultural technicians and officials across 30+ countries.

Awards and Honors

Dr. Tan’s achievements include the second prize in the Science and Technology Progress of Henan Province and the Science and Technology Award of the Plant Protection Society in 2020. She has also earned accolades for outstanding youth scientific papers.

Research Interests

Dr. Tan’s research revolves around insect molecular ecology, climate change impact on trophic systems, and green pest control strategies. Her innovative approaches combine ecological regulation with advanced pest management, focusing on sustainable agricultural practices.

đź“š Publications

Reduced insecticide susceptibility of the wheat aphid Sitobion miscanthi

  • Journal: Pest Management Science
  • Publication Date: April 2021
  • DOI: 10.1002/ps.6221
  • Contributors: Qian Li, JingXuan Sun, YaoGuo Qin, Jia Fan, Yong Zhang, XiaoLing Tan, MaoLin Hou, JuLian Chen

Conclusion 

Dr. Xiaoling Tan exemplifies research excellence, global collaboration, and impactful innovation in agricultural sustainability. Her contributions significantly advance ecological pest management and sustainable farming practices.

 

Neslihan Ă–zcanarslan | Depression | Best Researcher Award

Assist.Prof.Dr. Neslihan Ă–zcanarslan | Depression | Best Researcher Award

Assist.Prof.Dr. at Toros University, Turkey

Assist. Prof. Dr. Neslihan Ă–zcanarslan is an academician and researcher at Toros University, specializing in Public Health Nursing. She holds a Bachelor’s degree in Nursing from Cukurova University, a Master’s in Nursing from the same institution, and a Doctorate in Public Health Nursing from Gaziantep University. Her research focuses on critical areas such as women’s health, disaster nursing, infection control, and chronic diseases, with particular attention to mental health and resilience in healthcare workers. Dr. Ă–zcanarslan has contributed to various international research projects, including COST Action CA23113, and has published widely in reputable journals. She is a member of the Turkish Nurses Association and the Turkish Ostomy Surgery Association.

Profile

Scopus

Orcid

Education 🎓

Assist. Prof. Dr. Neslihan Ă–zcanarslan holds an extensive academic background, beginning with her Bachelor’s degree in Nursing from Cukurova University (2000-2004). She further pursued a Master’s degree in Nursing at Cukurova University, where her thesis focused on the determination of nurses’ stressors in the work environment, completed in February 2010. Dr. Ă–zcanarslan earned her Doctorate in Public Health Nursing from Gaziantep University (2018-2022), where her thesis addressed the Turkish validity and reliability of the Depression Scale for young people with epilepsy, a critical area in neurological health. This diverse educational background underpins her expertise in public health, nursing, and psychological health research.

Work Experience đź’Ľ

Assist. Prof. Dr. Neslihan Ă–zcanarslan has a diverse professional background that spans both academic and clinical settings. Currently serving as an Associate Professor at Toros University in the Faculty of Health Sciences, she teaches and conducts research in Public Health Nursing. Prior to her academic career, Dr. Ă–zcanarslan gained hands-on experience as a nurse with the Ministry of Health (2018-2022), and held roles such as Infection Control Nurse at Hatay Mustafa Kemal University (2012-2013) and Operating Room Nurse at Special Metro Hospital (2008-2011). Her extensive clinical experience is complemented by her leadership in various research projects and social initiatives, including a collaboration with Mersin Metropolitan Municipality and other universities in the “Women in the Light of the Future” project.

Awards and Honors

Assist. Prof. Dr. Neslihan Ă–zcanarslan has received recognition for her significant contributions to nursing and public health. Her dedication to advancing research in various health-related fields, such as women’s health, disaster nursing, and infection control, has earned her widespread acclaim. While specific awards and honors are not detailed in her profile, her work, including her involvement in the COST Action CA23113 project and the impactful “Women in the Light of the Future” project, highlights her commitment to creating meaningful change in public health and nursing. Her scholarly achievements, as evidenced by numerous publications, further underscore her contributions to the field.

Research Interests

Assist. Prof. Dr. Neslihan Ă–zcanarslan’s research interests span a wide range of topics within nursing and public health. She focuses on critical areas such as infection control, operating room nursing, geriatrics, home care nursing, disaster nursing, and epilepsy. Additionally, her work extends to addressing chronic diseases, addiction, and women’s health, with a strong emphasis on community, school, adolescent, and child health. Dr. Ă–zcanarslan also explores issues surrounding breast milk and infant nutrition, immunization, disability, violence, abuse, and occupational health and safety. Her multidisciplinary approach aims to improve public health services and contribute to the well-being of diverse populations, particularly those in vulnerable or underserved communities.

đź“š Publications

Title: The Impact of Intensive Care Unit Nurses’ Burnout Levels on Turnover Intention and the Mediating Role of Psychological Resilience
Authors: Turunç, Ö., Çalışkan, A., Akkoç, İ., Hazır, K., Özcanarslan, N.
Journal: Behavioral Sciences
Year: 2024
Volume: 14
Issue: 9
Article Number: 782

Conclusion 

Dr. Neslihan Ă–zcanarslan’s diverse and impactful work in health research, particularly in public health nursing, makes her an ideal candidate for the Research for Best Researcher Award. Her ongoing commitment to global health and her efforts to enhance public health systems through research and collaboration underline her exceptional qualifications.

 

Chul-Hyun Park | NeuroRehabilitation | Best Faculty Award

Mr. Chul-Hyun Park | NeuroRehabilitation | Best Faculty Award

Professor at Kangbuk Samsung Hospital, Sungkyunkwan University School of Medicine, South Korea

Dr. Chul-Hyun Park, born in Seoul, South Korea, is a highly accomplished medical professional specializing in rehabilitation medicine. He earned his M.D. in 2013 and further advanced his education with a Master’s and Ph.D. from Chung-Ang University, School of Medicine. He completed rigorous training at Samsung Kangbuk Hospital and Seoul National University Hospital, obtaining board certifications in Rehabilitation Medicine (2018) and Sports Medicine (2019). Since 2020, he has been serving as a Clinical Professor at Samsung Kangbuk Hospital, Sungkyunkwan University, where he combines clinical practice with academic responsibilities. Dr. Park has published over 20 SCI/SCIE-indexed research papers and is recognized for his expertise in musculoskeletal rehabilitation, pediatric care, trauma recovery, and sports medicine. He is skilled in advanced interventions like spinal pain management, musculoskeletal ultrasound, and spasticity control. Actively involved in professional organizations and editorial boards, Dr. Park continues to contribute significantly to the advancement of rehabilitation medicine.

Profile

Orcid

Education 🎓:

Dr. Chul-Hyun Park completed his Bachelor of Medicine from Dankook University, School of Medicine, Cheonan, South Korea, in 2013. He pursued advanced studies at Chung-Ang University, School of Medicine, where he earned a Master of Science in Medicine in 2017. Demonstrating his commitment to academic excellence and specialization, he completed his PhD in Physical and Rehabilitation Medicine in 2020. His academic journey reflects a robust foundation and an unwavering dedication to the field of rehabilitation medicine.

Work Experience đź’Ľ:

Dr. Chul-Hyun Park has an extensive and distinguished career in the field of rehabilitation medicine. After completing his medical degree in 2013, he pursued specialized training at Samsung Kangbuk Hospital and Seoul National University Hospital. From 2014 to 2018, he underwent residency and internship at Samsung Kangbuk Hospital, where he honed his clinical skills in physical and rehabilitation medicine. He then served as a Clinical Fellow (2018-2019) and Research Professor (2019-2020) at Seoul National University Hospital, further advancing his expertise in musculoskeletal, pediatric, and trauma rehabilitation. Since 2020, Dr. Park has been a Clinical Professor at Samsung Kangbuk Hospital, Sungkyunkwan University, where he continues to contribute to clinical practice, research, and education in rehabilitation medicine. Throughout his career, Dr. Park has developed expertise in various therapeutic interventions, including spinal pain management, spasticity control, and musculoskeletal ultrasound-guided treatments, making him a leader in his field.

Awards and Honors

Dr. Chul-Hyun Park has earned recognition for his exceptional contributions to the field of rehabilitation medicine. He was awarded board certification in Rehabilitation Medicine in 2018 and in Sports Medicine in 2019, underscoring his advanced clinical expertise. Additionally, Dr. Park has received a Musculoskeletal Ultrasound Quality Control Certificate in 2018, reflecting his proficiency in diagnostic and therapeutic techniques. His research excellence has been acknowledged through multiple publications in SCI/SCIE journals, highlighting his significant impact on the academic community. As a testament to his leadership, he holds editorial roles with the Korean Academy of Rehabilitation Medicine and The Korean Association of Pain Medicine, demonstrating his influence in advancing the field.

Research Interests:

Dr. Chul-Hyun Park’s research interests are centered around advancing the field of rehabilitation medicine, with a particular focus on musculoskeletal rehabilitation, pediatric rehabilitation, and trauma recovery. His work explores innovative treatment strategies for chronic pain, including spinal pain interventions and musculoskeletal ultrasound-guided injection techniques. Additionally, Dr. Park is deeply involved in research related to pediatric rehabilitation, especially in managing spasticity in cerebral palsy, and enhancing recovery in burn and trauma patients. His studies also extend to sports medicine, cardiopulmonary rehabilitation, and the integration of gut microbiota with muscle health. Dr. Park’s research aims to improve clinical outcomes and develop effective therapeutic approaches, contributing to both the scientific community and patient care advancements.

đź“š Publications

  • Sex-Specific Association of Low Muscle Mass with Depression Status in Asymptomatic Adults: A Population-Based Study
    • Journal: Brain Sciences
    • Publication Date: 2024-10-30
    • DOI: 10.3390/brainsci14111093
    • Contributors: Sung Joon Cho, Sra Jung, Mi-Yeon Lee, Chul Hyun Park
  • Sex Differences in the Association between Prolonged Sitting Time and Anxiety Prevalence among Korean Adults
    • Journal: Brain Sciences
    • Publication Date: 2024-07
    • DOI: 10.3390/brainsci14070729
    • Contributors: Eunsoo Kim, Chul-Hyun Park, Hyun-Seung Lee, Mi Yeon Lee, Sung Joon Cho
  • Exploring the Association between Elevated Anxiety Symptoms and Low Skeletal Muscle Mass among Asymptomatic Adults: A Population-Based Study in Republic of Korea
    • Journal: Brain Sciences
    • Publication Date: 2024-04-28
    • DOI: 10.3390/brainsci14050438
    • Contributors: Eunsoo Kim, Sra Jung, Mi Yeon Lee, Chul-Hyun Park, Sung Joon Cho
  • The Association of Carbohydrate Antigen (CA) 19-9 Levels and Low Skeletal Muscle Mass in Healthy Adults
    • Journal: Nutrients
    • Publication Date: 2023-07-30
    • DOI: 10.3390/nu15153394
    • Contributors: Jae Hyun Lee, Dong-Kun Kim, Mi-Yeon Lee, Han-Sol Lim, Min-Jung Kwon, Yong-Taek Lee, Kyung Jae Yoon, Chul-Hyun Park
  • Association of Pulmonary Function with Osteosarcopenic Obesity in Older Adults Aged over 50 Years
    • Journal: Nutrients
    • Publication Date: 2023-06-28
    • DOI: 10.3390/nu15132933
    • Contributors: Han-Sol Lim, Dong-Kun Kim, Hyun-Il Gil, Mi-Yeon Lee, Hyun-Seung Lee, Yong-Taek Lee, Kyung Jae Yoon, Chul-Hyun Park

Conclusion 

Dr. Chul-Hyun Park is a highly suitable candidate for the Research for Best Faculty Award. His extensive research contributions, innovative clinical skills, and dedication to academic excellence epitomize the qualities recognized by this prestigious honor.

 

Qinjun Chu | Parkinson’s Disease | Best Researcher Award

Prof. Dr. Qinjun Chu | Parkinson’s Disease | Best Researcher Award

Director of Anesthesiology and Perioperative Medicine, Head of the Information Technology Department at Zhengzhou Central Hospital Affiliated to Zhengzhou University, China

Prof. Dr. Qinjun Chu is a renowned expert in anesthesiology, holding a Doctorate in Anesthesiology from Zhengzhou University. He serves as the Director of Anesthesiology and Perioperative Medicine and Head of the Information Technology Department at Zhengzhou Central Hospital, affiliated with Zhengzhou University. With over 47 published papers in SCI and Scopus-indexed journals, his research focuses on perioperative pain management, airway management, nerve blocks, cardiac ultrasound, and neurodegenerative diseases. Notable innovations include a virtual pain unit, a proposed deep cervical lymphovenous bypass surgery for Parkinson’s treatment, and a rotational cutting device for hypertrophic cardiomyopathy. Prof. Chu is a member of various professional associations, including the Chinese Medical Association and the Henan Anesthesiologists Association.

Profile

Scopus

Education 🎓:

Prof. Dr. Qinjun Chu completed his academic journey with a Doctorate in Anesthesiology from Zhengzhou University. His extensive educational foundation in anesthesiology has propelled him into a distinguished career in both clinical practice and research, allowing him to make significant advancements in areas such as perioperative pain management and nerve blocks.

Work Experience đź’Ľ:

Prof. Dr. Qinjun Chu has extensive professional experience in anesthesiology and perioperative medicine. He currently serves as the Director of Anesthesiology and Perioperative Medicine at Zhengzhou Central Hospital, affiliated with Zhengzhou University. Additionally, he heads the Information Technology Department at the same institution. His work spans various clinical and research domains, including the development of wearable cardiac ultrasound and advancements in myectomy for hypertrophic cardiomyopathy. Prof. Chu has also made significant contributions to training and promoting transesophageal ultrasound and nerve blockade techniques. He is an active member of several prestigious committees, including the Chinese Medical Association’s Anesthesiology Branch and the Henan Anesthesiologists Association.

Awards and Honors

Prof. Dr. Qinjun Chu has received numerous accolades throughout his career for his exceptional contributions to anesthesiology and perioperative medicine. He is recognized for his pioneering work in perioperative pain management, airway management, and cardiac ultrasound. His innovations in developing virtual pain units and proposing new treatment methods for neurodegenerative diseases and hypertrophic cardiomyopathy have earned him significant recognition within the medical community. Prof. Chu’s dedication to advancing the field has also led to his appointment as the director of the Zhengzhou Anesthesia Quality Control Center. His work continues to be highly regarded by peers and medical professionals alike.

Research Interests:

Prof. Dr. Qinjun Chu’s research interests encompass a wide range of topics within anesthesiology and perioperative medicine. His primary focus lies in perioperative pain management, airway management, and nerve blocks, aiming to improve patient outcomes during surgery and recovery. He has also made significant contributions to the field of cardiac ultrasound, particularly through his work in developing wearable cardiac ultrasound devices. Additionally, Prof. Chu is dedicated to advancing the treatment of neurodegenerative diseases, with a specific interest in Parkinson’s disease. His innovative approaches, such as deep cervical lymphovenous bypass surgery and new devices for hypertrophic cardiomyopathy, highlight his commitment to enhancing patient care.

đź“š Publications

  • Title: Inhibition of KIF5b-mediated Nav1.8 transport by ropivacaine contributes to axonal regeneration following sciatic nerve injury in rats
    Authors: Cui, Y., Chu, Q., Jin, X., Zhao, Z., Zhang, J.
    Journal: Neuropharmacology
    Volume: 261
    Article Number: 110169
    Citations: 0
  • Title: Letter to the Editor Regarding “Clinical Application of Different Doses of Hydromorphone Slow-Release Analgesia in Lumbar Fusion in Elderly Patients” (Letter – Open access)
    Authors: Yang, G., Chu, Q.
    Journal: Pain and Therapy
    Volume: 13(6)
    Pages: 1715–1716
    Citations: 1
  • Title: Ultrasound-guided suprainguinal fascia iliaca compartment block and early postoperative analgesia after total hip arthroplasty. Comment on Br J Anaesth 2024; 133: 146–51 (Letter)
    Authors: Yang, G., Chu, Q.
    Journal: British Journal of Anaesthesia
    Volume: 133(6)
    Pages: 1328–1329
    Citations: 0
  • Title: Letter to the editor regarding “Assessing different brain oxygenation components in elderly patients under propofol or sevoflurane anesthesia: A randomized controlled study” (Letter)
    Authors: Yang, G., Chu, Q.
    Journal: Journal of Clinical Anesthesia
    Volume: 99
    Article Number: 111634
    Citations: 0
  • Title: Gut microbiota dysbiosis and neurological function recovery after intracerebral hemorrhage: an analysis of clinical samples (Article – Open access)
    Authors: Wang, Y., Bing, H., Jiang, C., Xia, Z., Chu, Q.
    Journal: Microbiology Spectrum
    Volume: 12(11)
    Citations: 1
  • Title: Letter to the editor regarding “Postoperative delirium risk in patients with hyperlipidemia: A prospective cohort study” (Letter)
    Authors: Yang, G., Chu, Q.
    Journal: Journal of Clinical Anesthesia
    Volume: 98
    Article Number: 111584
    Citations: 0
  • Title: Comment on: Effects of pregabalin combined with tramadol/paracetamol on acute pain in patients with CT-guided puncture localization of pulmonary nodules (Letter)
    Authors: Yang, G., Chu, Q.
    Journal: Lung Cancer
    Volume: 196
    Article Number: 107938
    Citations: 0

Conclusion 

Prof. Dr. Qinjun Chu’s dedication to research and innovation, coupled with his extensive contributions to anesthesiology and clinical treatments, makes him a highly deserving candidate for the Best Researcher Award.